11:30 AM SIGN-IN & LUNCH • 12:00 PM - 1:30 PM

BANDOL 1 (NEW WYNN SPACE)

CE: Influenza Treatment: Exploring the Clinical and Economic Benefits of Antivirals

Despite the worldwide concern of influenza every season, the burden remains high, with an estimated 36 million individuals having symptomatic illnesses in the United States in the 2018-2019 season. Antivirals are important in not just decreasing symptoms associated with influenza, but also in reducing complications that may require additional treatment or hospitalization. It is imperative that pharmacists are able to identify individuals who are at high risk of serious influenza-related complications and understand the nuances of the 4 approved antivirals recommended by the CDC this season: baloxavir, oseltamivir, peramivir, and zanamivir. Improving clinical and economic outcomes necessitates an understanding of appropriate diagnostic testing to initiate antiviral therapy, improving timing of antiviral therapy, and assisting with patient access.

Speakers

Jeffrey Dunn

Carlene Muto

Asembia

200 Park Avenue, Suite 300 
Florham Park, NJ 07932

973.564.8004

asembia.com

info@asembiasummit.com

SIGN UP FOR SUMMIT UPDATES

Asembia's Specialty Pharmacy Summit is a PRIVATE EVENT. Asembia reserves the right to deny registration and refuse access at our absolute and sole discretion for any reason whatsoever.

Virtual Experience Terms & Conditions

© 2020 Asembia Specialty Pharmacy Summit, LLC. All rights reserved.

CONNECT WITH US

  • Asembia LinkedIn
  • Asembia Twitter
  • Asembia Instagram
  • Asembia Facebook
  • Asembia Videos
  • Asembia Photos
SummitLogo_2020_White.png